HAVCR2 and cancer: TIM-3 +4259T/G polymorphism was only associated with an increased risk of other cancer (TG vs. TT: OR = 2.87, 95%CI: 2.04-4.02, Pz < 0.01; G vs. T: OR = 2.77, 95%CI: 1.98-3.87, Pz < 0.01).